Biotika

1BSL01AE

CS0009013453

Pharmaceuticals

End-of-day quote Bratislava S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
23.8 ^EUR	-4.80%		-1.65%	+9.17%

Apr. 25	Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2021

April 28, 2022 at 09:23 pm EDT

Biotika a.s. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 8.91 million compared to EUR 17.65 million a year ago. Revenue was EUR 16.58 million compared to EUR 19.28 million a year ago. Net income was EUR 0.40571 million compared to EUR 2.28 million a year ago.

Latest news about Biotika

Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Biotika A.S. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-23	CI
Biotika A.S. Reports Earnings Results for the Full Year Ended December 31, 2019	20-09-08	CI
Biotika AS’ Equity Buyback announced on August 8, 2014 has expired.	14-12-30	CI
Biotika AS announces an Equity Buyback for 81,000 shares.	14-08-07	CI
Biotika AS authorizes a Buyback Plan.	14-08-04	CI

Chart Biotika

Duration

Period

More charts

Company Profile

Biotika as is a Slovakia-based joint stock company that specializes in biotechnology and production of pharmaceutical. The Company's activities are grouped into three main areas: biotechnological production of the substances of penicillin, chlorotetracycline and dextrans; production of final drug-forms for both human and veterinary use, including: penicillin and cephalosporin preparations, hormonal preparations, vitamin preparations; as well as production of premixes containing nutrition additives and medicated nutritive preparations. As of December 31, 2011, the Company operated two wholly owned subsidiaries, COV as Slovenska Lupca and Biotkika KLF as Slovenska Lupca.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BIOTIKA	+9.17%	24.98M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B